Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ideaya Biosciences Inc (IDYA)

Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Fri May 1, 5:00AM CDT

SOUTH SAN FRANCISCO, Calif. , May 1, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics,...

IDYA : 28.19 (-3.13%)
IDEAYA Biosciences Announces Late-Breaking Abstract Oral Presentation at ASCO 2026 to Provide Complete Data from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in 1L HLA*A2-Negative Metastatic Uveal Melanoma PR Newswire - Tue Apr 21, 9:15AM CDT

SOUTH SAN FRANCISCO, Calif. , April 21, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced they have been selected for a...

IDYA : 28.19 (-3.13%)
American flag on NY Stock Exchange by Chameleonseye via iStock
Stocks Settle Higher in Hopes for an Agreement to End the Iran War Barchart - Mon Apr 13, 3:37PM CDT

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +1.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.06%. June E-mini S&P...

IDYA : 28.19 (-3.13%)
AVGO : 421.28 (+0.92%)
INTU : 399.04 (+2.71%)
SNDK : 1,187.00 (+8.25%)
SRE : 94.67 (-0.47%)
$IUXX : 27,710.36 (+0.94%)
ZNM26 : 110-205s (+0.04%)
ESM26 : 7,258.00s (+0.20%)
QCOM : 177.01 (-1.43%)
STX : 726.93 (+7.91%)
BBY : 60.05 (-0.73%)
$DOWI : 49,499.27 (-0.31%)
Nasdaq Times Square by Lucky Photographer via iStock
Stocks Recover as Oracle Leads Software Companies Higher Barchart - Mon Apr 13, 10:09AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.09%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.16%. June E-mini S&P futures (ESM26...

ALK : 38.55 (-1.43%)
UAL : 92.52 (+2.80%)
IDYA : 28.19 (-3.13%)
INTU : 399.04 (+2.71%)
SNDK : 1,187.00 (+8.25%)
$IUXX : 27,710.36 (+0.94%)
ZNM26 : 110-205s (+0.04%)
ESM26 : 7,258.00s (+0.20%)
NCLH : 18.81 (+3.47%)
BBY : 60.05 (-0.73%)
$DOWI : 49,499.27 (-0.31%)
SPY : 720.65 (+0.28%)
Strait of Hormuz by artemegorovv via Shutterstock
Stocks Mixed as US Set to Blockade the Strait of Hormuz Barchart - Mon Apr 13, 8:57AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.21%. Stock indexes are mixed this...

ALK : 38.55 (-1.43%)
MSTR : 177.17 (+7.08%)
UAL : 92.52 (+2.80%)
IDYA : 28.19 (-3.13%)
CVX : 190.63 (-1.39%)
SNDK : 1,187.00 (+8.25%)
GLXY : 28.11 (+2.44%)
$IUXX : 27,710.36 (+0.94%)
COIN : 191.25 (+1.85%)
ZNM26 : 110-205s (+0.04%)
OXY : 58.71 (-3.09%)
FANG : 207.65 (+0.98%)
IDEAYA Biosciences and Servier Announce Positive Topline Results from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA-A*02:01-Negative Metastatic Uveal Melanoma PR Newswire - Mon Apr 13, 5:00AM CDT

SOUTH SAN FRANCISCO, Calif. , April 13, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, and Servier, an independent international pharmaceutical...

IDYA : 28.19 (-3.13%)
IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026 PR Newswire - Fri Apr 10, 3:05PM CDT

SOUTH SAN FRANCISCO, Calif. , April 10, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, today announced plans to issue a joint IDEAYA and Servier...

IDYA : 28.19 (-3.13%)
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer PR Newswire - Mon Apr 6, 5:00AM CDT

SOUTH SAN FRANCISCO, Calif. , April 6, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been...

IDYA : 28.19 (-3.13%)
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3 Upregulated Solid Tumor Indications, including SCLC, NETs, NECs, and Melanoma PR Newswire - Mon Mar 30, 5:00AM CDT

SOUTH SAN FRANCISCO, Calif. , March 30, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted...

IDYA : 28.19 (-3.13%)
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Fri Mar 27, 5:00AM CDT

SOUTH SAN FRANCISCO, Calif. , March 27, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted...

IDYA : 28.19 (-3.13%)

Barchart Exclusives

Jobs, Earnings and Other Key Things to Watch this Week Barchart - 25 minutes ago
Markets enter a big week following last week's Federal Reserve meeting and mega-cap technology earnings convergence, with focus now shifting to Friday's April jobs report at 8:30am that will provide insights into labor market health amid geopolitical uncertainties and energy-driven economic pressures. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.